Declared bankruptcy in Sep 2023
SRGA - Surgalign Holdings, Inc.
NASDAQ
->
Healthcare
->
Medical Devices
Deerfield,
United States
Type: Equity
SRGA price evolution
SRGA
| (in millions $) | 31 Mar 2023 | 31 Jan 2023 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $22.43 | $16.3 | $13.85 | $29.34 |
| Short term investments | ||||
| Net receivables | $12.57 | $21.77 | $18.94 | $20.5 |
| Inventory | $19.68 | $17.71 | $38.32 | $37.07 |
| Total current assets | $53.43 | $56.71 | $66.65 | $86.8 |
| Long term investments | ||||
| Property, plant & equipment | $2.42 | $3.02 | $1.78 | $1.32 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $14.28 | $13.53 | $21.39 | $18.89 |
| Total investments | ||||
| Total assets | $67.71 | $70.24 | $88.04 | $105.7 |
| Current liabilities | ||||
| Accounts payable | $7.49 | $7.71 | $13.06 | $10.56 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $19.98 | $21.15 | $34.69 | $37.25 |
| Long term debt | $10.24 | $10.19 | $10.14 | $10.09 |
| Total noncurrent liabilities | $56.66 | $64.82 | $30.97 | $37.61 |
| Total debt | $10.24 | $10.19 | $10.14 | $10.09 |
| Total liabilities | $76.64 | $85.97 | $65.66 | $74.86 |
| Shareholders' equity | ||||
| Retained earnings | -$620.07 | -$624.22 | -$585.11 | -$575.27 |
| Other shareholder equity | -$3.35 | -$2.84 | -$2.06 | -$2.24 |
| Total shareholder equity | -$18.93 | -$25.73 | $12.38 | $20.84 |
| (in millions $) | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $16.3 | $51.29 | $43.96 | $5.61 |
| Short term investments | ||||
| Net receivables | $21.77 | $19.2 | $27.09 | $59.29 |
| Inventory | $17.71 | $36.42 | $30.7 | $130.79 |
| Total current assets | $56.71 | $105.67 | $104.18 | $195.81 |
| Long term investments | ||||
| Property, plant & equipment | $3.02 | $0.94 | $0.52 | $69.89 |
| Goodwill & intangible assets | $65.88 | |||
| Total noncurrent assets | $13.53 | $18.13 | $18.52 | $148.69 |
| Total investments | ||||
| Total assets | $70.24 | $123.8 | $122.7 | $344.51 |
| Current liabilities | ||||
| Accounts payable | $7.71 | $10.2 | $13.42 | $30.13 |
| Deferred revenue | $2.75 | |||
| Short long term debt | $174.18 | |||
| Total current liabilities | $21.15 | $54.04 | $46.82 | $240.39 |
| Long term debt | $10.19 | $9.98 | ||
| Total noncurrent liabilities | $64.82 | $51.51 | $51.71 | $3.15 |
| Total debt | $10.19 | $9.98 | $174.18 | |
| Total liabilities | $85.97 | $105.56 | $98.53 | $243.53 |
| Shareholders' equity | ||||
| Retained earnings | -$624.22 | -$569.61 | -$484.96 | -$451.18 |
| Other shareholder equity | -$2.84 | -$1.82 | -$2.42 | -$7.63 |
| Total shareholder equity | -$25.73 | $8.24 | $24.17 | $34.56 |
| (in millions $) | 1 May 2023 | 31 Dec 2022 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $20.57 | $20.18 | $20.62 | |
| Cost of revenue | $23.38 | $5.49 | $6.41 | |
| Gross Profit | -$2.81 | $14.69 | $14.21 | |
| Operating activities | ||||
| Research & development | $3.33 | $3.87 | $4.08 | |
| Selling, general & administrative | $22.43 | $23.86 | $24.29 | |
| Total operating expenses | $45.35 | $22.69 | $27.6 | |
| Operating income | -$48.16 | -$8 | -$13.39 | |
| Income from continuing operations | ||||
| EBIT | -$40.19 | -$9.54 | -$5.34 | |
| Income tax expense | -$1.33 | $0.04 | $0.09 | |
| Interest expense | $0.25 | $0.25 | $0.25 | |
| Net income | ||||
| Net income | -$39.11 | -$9.83 | -$5.69 | |
| Income (for common shares) | -$39.11 | -$9.83 | -$5.69 | |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $81.98 | $90.5 | $101.75 | $308.38 |
| Cost of revenue | $41.69 | $29.77 | $44 | $137.26 |
| Gross Profit | $40.29 | $60.73 | $57.75 | $171.13 |
| Operating activities | ||||
| Research & development | $15.74 | $13.89 | $11.95 | $16.84 |
| Selling, general & administrative | $95.89 | $104.67 | $124.39 | $157.68 |
| Total operating expenses | $118.75 | $198.01 | $255.77 | $352.98 |
| Operating income | -$78.46 | -$137.28 | -$198.02 | -$181.86 |
| Income from continuing operations | ||||
| EBIT | -$54.64 | -$85.54 | -$37.24 | -$181.83 |
| Income tax expense | -$1.04 | -$0.89 | -$3.49 | $17.24 |
| Interest expense | $1.01 | $0.03 | $12.57 | |
| Net income | ||||
| Net income | -$54.6 | -$84.65 | -$33.78 | -$211.64 |
| Income (for common shares) | -$54.6 | -$84.65 | -$33.78 | -$211.64 |
| (in millions $) | 1 May 2023 | 31 Dec 2022 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Net income | -$39.11 | -$9.83 | -$5.69 | |
| Operating activities | ||||
| Depreciation | $0.45 | $0.55 | $0.62 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.12 | $1.21 | $0.93 | |
| Total cash flows from operations | -$6.32 | -$13.38 | -$13.27 | |
| Investing activities | ||||
| Capital expenditures | -$1.59 | -$2.16 | -$1.77 | |
| Investments | ||||
| Total cash flows from investing | $15.67 | -$1.72 | -$2.32 | -$1.88 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $10.89 | -$0.01 | $0.14 | |
| Net borrowings | ||||
| Total cash flows from financing | -$0.02 | $10.89 | -$0.01 | $0.14 |
| Effect of exchange rate | -$0.49 | -$0.4 | $0.21 | -$0.32 |
| Change in cash and equivalents | $6.13 | $2.45 | -$15.5 | -$15.33 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | -$54.6 | -$84.65 | -$33.78 | -$211.64 |
| Operating activities | ||||
| Depreciation | $2.18 | $2.48 | $6.58 | $22.68 |
| Business acquisitions & disposals | -$10.76 | $404.98 | -$99.69 | |
| Stock-based compensation | $4.63 | $5.21 | $6.53 | $4.37 |
| Total cash flows from operations | -$52.11 | -$51.79 | -$88.04 | -$9.46 |
| Investing activities | ||||
| Capital expenditures | -$6.78 | -$13.42 | -$10.12 | -$14.43 |
| Investments | ||||
| Total cash flows from investing | -$7.26 | -$24.83 | $390.94 | -$116.13 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $28.74 | $82.56 | -$0.49 | $0.12 |
| Net borrowings | -$196.03 | $120.17 | ||
| Total cash flows from financing | $24.66 | $82.56 | -$263.04 | $120.3 |
| Effect of exchange rate | -$0.28 | $1.39 | -$1.51 | -$0.06 |
| Change in cash and equivalents | -$34.99 | $7.33 | $38.35 | -$5.34 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 7.78M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | -2.00 |
| Cash/Share | 2.88 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | -3.34 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.67 |
| Quick ratio | 1.69 |